AU Patent

AU2011205290B2 — Use of an adrenal hormone-modifying agent

Assigned to Recordati SA · Expires 2014-06-26 · 12y expired

What this patent protects

The present invention relates to a method of treating a disease or disorder characterised by increased stress hormone levels and/or decreased androgen hormone levels in a subject, comprising administering to the subject a therapeutically effective amount of a compound represented…

USPTO Abstract

The present invention relates to a method of treating a disease or disorder characterised by increased stress hormone levels and/or decreased androgen hormone levels in a subject, comprising administering to the subject a therapeutically effective amount of a compound represented by formula (I): wherein n is 1 or 3; R is hydrogen or --C(O)N(R

Drugs covered by this patent

Patent Metadata

Patent number
AU2011205290B2
Jurisdiction
AU
Classification
—
Expires
2014-06-26
Drug substance claim
No
Drug product claim
No
Assignee
Recordati SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.